本頁面由Tiger Trade Technology Pte. Ltd.提供服務

梯瓦製藥

33.62
-0.3000-0.88%
盤後34.100.4788+1.42%18:36 EST
成交量:351.11萬
成交額:1.19億
市值:391.67億
市盈率:27.79
高:34.13
開:34.00
低:33.60
收:33.92
52周最高:37.35
52周最低:12.47
股本:11.65億
流通股本:11.42億
量比:0.58
換手率:0.31%
股息:- -
股息率:- -
每股收益(TTM):1.21
每股收益(LYR):1.21
淨資產收益率:20.79%
總資產收益率:6.17%
市淨率:4.95
市盈率(LYR):27.79

資料載入中...

公司資料

公司名字:
梯瓦製藥
交易所:
NYSE
成立時間:
1901
員工人數:
32008
公司地址:
124 Dvora HaNevi’a St.,Tel Aviv-Yafo,Israel
郵編:
6944020
傳真:
- -
簡介:
Teva Pharmaceutical Industries Limited於1944年2月13日在以色列註冊成立。該公司是一家全球性生物製藥公司,擁有重要的仿製藥業務,在全球約57個市場開展業務。它專註於神經科學和免疫學領域的創新,同時提供複雜的仿製藥、生物仿製藥和藥房品牌,以滿足患者的需求。

董事

名稱
職位
Kare Schultz
Director and President and Chief Executive Officer
Sol J. Barer
Chairman of the Board of Directors
Amir Elstein
董事
Dan S. Suesskind
董事
Gabrielle Sulzberger
董事
Galia Maor
董事
Gerald M. Lieberman
董事
Jean Michel Halfon
董事
Murray Goldberg
董事
Nechemia J. Peres
董事
Perry D. Nisen
董事
Roberto A. Mignone
董事
Rosemary A. Crane
董事

股東

名稱
職位
Kare Schultz
Director and President and Chief Executive Officer
Michael McClellan
Executive Vice President, Chief Financial Officer
Brendan O'Grady
Executive Vice President, North America Commercial
Carlo de Notaristefani
Executive Vice President, Global Operations
David M. Stark
Executive Vice President, Chief Legal Officer
Gianfranco Nazzi
Executive Vice President, Growth Markets Commercial
Hafrun Fridriksdottir
Executive Vice President, Global R&D
Iris Beck Codner
Executive Vice President, Global Brand and Communications
Mark Sabag
Executive Vice President, Global Human Resources
Richard Daniell
Executive Vice President, European Commercial
Sven Dethlefs
Executive Vice President, Global Marketing & Portfolio